Galmed Pharmaceuticals Ltd.

NAS: GLMD

GO
/marketstate/country/us

Market open

/zigman2/quotes/205112634/composite

$

3.59

Change

-0.05 -1.37%

Volume

Volume 192,790

Sep 25, 2020, 12:47 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205112634/composite

Previous close

$ 3.64

$ 3.59

Change

-0.05 -1.37%

Day low

Day high

$3.59

$3.70

Open
Open: 3.65

52 week low

52 week high

$3.02

$7.38

Open

Market cap

$76.85M

Average volume

70,405

P/E ratio

N/A

Rev. per Employee

$97,048

EPS

-1.15

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/glmd

MarketWatch News on GLMD

  1. Galmed Pharmaceuticals downgraded to neutral from buy at B. Riley FBR

    7:50 a.m. May 22, 2020

    - Tomi Kilgore

  2. Galmed Pharmaceuticals started at buy with $29 stock price target at Canaccord Genuity

    2:58 p.m. Dec. 2, 2019

    - Tomi Kilgore

  3. Galmed Pharmaceuticals started at buy with $35 stock price target at Stifel Nicolaus

    7:26 a.m. July 13, 2018

    - Tomi Kilgore

  4. Stocks end modestly higher as investors await Fed rate decision

    4:27 p.m. June 12, 2018

    - Anora M. Gaudiano

  5. Galmed’s 200% Jump Leads Biotechs Higher

    11:26 a.m. June 12, 2018

    - Barrons Blogs

  6. Galmed Pharmaceuticals downgraded to hold from buy at Maxim Group

    10:21 a.m. Feb. 14, 2018

    - Tomi Kilgore

  7. Gilead Sciences: A Nash Smashup in Pharma?

    11:48 a.m. Oct. 25, 2017

    - Barrons Blogs

  8. Biotech: Why NASH is So Hot Right Now

    3:16 p.m. Sept. 21, 2016

    - Barrons Blogs

  9. Galmed Pharmaceuticals stock price target cut to $9 from $24 at Maxim Group

    7:26 a.m. Aug. 1, 2016

    - Tomi Kilgore

  10. Galmed Could Double, Even With Reduced Outlook

    11:56 a.m. Aug. 2, 2016

    - Barron's Online

  11. Gilead Buy Could Bolster Galmed Valuation

    10:34 a.m. April 6, 2016

    - Barron's Online

  12. Two Picks Boosted by Intercept NASH Trial

    7:40 a.m. May 22, 2015

    - Barron's Online

/news/nonmarketwatch/company/us/glmd

Other News on GLMD

  1. Week In Review: Baidu Raising $2 Billion For New China Biopharma

    11:40 a.m. Sept. 13, 2020

    - Seeking Alpha

  2. Intercept (ICPT) Posts New Positive Results on NASH Drug

    12:45 p.m. Aug. 28, 2020

    - Zacks.com

  3. Viking Therapeutics: Another Year In Review

    2:39 p.m. Aug. 13, 2020

    - Seeking Alpha

  4. IPO Update: Inventiva SA Looks For $102 Million U.S. IPO

    5:58 p.m. July 6, 2020

    - Seeking Alpha

  5. Intercept Slumps as the FDA Issues CRL to NASH Candidate

    10:29 a.m. June 30, 2020

    - Zacks.com

  6. Inventiva SA Starts U.S. IPO Rollout

    3:52 p.m. June 26, 2020

    - Seeking Alpha

  7. How Galmed (GLMD) Stock Stands Out in a Strong Industry

    8:34 a.m. June 10, 2020

    - Zacks.com

  8. After Drug Failure, Genfit's Cupboard Is Nearly Bare

    3:31 p.m. May 14, 2020

    - GuruFocus.com

  9. NASH: The Second Wave

    7:29 p.m. Feb. 20, 2020

    - Seeking Alpha

  10. Canaccord likes Madrigal Pharma in premarket analyst action

    9:27 a.m. Jan. 30, 2020

    - Seeking Alpha

  11. Madrigal: Beyond NASH

    1:35 p.m. Jan. 14, 2020

    - Seeking Alpha

  12. CPST, CRC, RVNC and ORMP among notable midday movers

    1:41 p.m. Dec. 4, 2019

    - Seeking Alpha

  13. Top Ranked Momentum Stocks to Buy for December 4th

    10:26 a.m. Dec. 4, 2019

    - Zacks.com

  14. Goldman neutral on Bausch Health in premarket analyst action

    9:59 a.m. Dec. 2, 2019

    - Seeking Alpha

  15. Loading more headlines...
/news/pressrelease/company/us/glmd

Press Releases on GLMD

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.